Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 29 peer-reviewed journal articles Updated
Pain Management

How Does IV Ketamine Infusion Therapy Treat CRPS?

At a Glance

IV ketamine infusion therapy treats Complex Regional Pain Syndrome (CRPS) by blocking NMDA receptors, which stops the continuous firing of pain signals. Administered at low doses, it temporarily "reboots" an overly sensitive nervous system to provide significant pain relief.

Intravenous (IV) ketamine infusion therapy has emerged as a valuable option for managing Complex Regional Pain Syndrome (CRPS), especially for patients who haven’t found relief through standard conservative treatments [1][2]. Ketamine works differently than traditional pain medications by targeting specific pathways in the brain and spinal cord to “reboot” the nervous system [3]. When administered at low, sub-anesthetic doses, it is generally considered safe and effective, with side effects that are typically minor and temporary [4][5].

How Ketamine “Reboots” the Nervous System

In people with CRPS, the nervous system becomes stuck in a state of high alert, constantly sending pain signals to the brain. This is driven by a process called central sensitization, where the spinal cord and brain become overly sensitive to ordinary touch and movement [6].

Ketamine interrupts this cycle by acting as an NMDA receptor antagonist. N-methyl-D-aspartate (NMDA) receptors are specific “docking stations” on nerve cells that process glutamate, a major chemical messenger that amplifies pain signals [3][7]. By blocking these NMDA receptors, ketamine prevents the continuous firing of pain signals, effectively turning down the volume of the nervous system and giving it a chance to reset [8].

Who Should Avoid Ketamine?

While ketamine is generally safe when properly monitored, it is not for everyone. Because ketamine can elevate blood pressure and heart rate, and can affect brain chemistry, comprehensive screening is required [9]. You may not be a candidate if you have:

  • Uncontrolled high blood pressure or severe cardiovascular disease.
  • A history of schizophrenia, psychosis, or certain severe psychiatric conditions, as ketamine can exacerbate these issues [10][11].

What the Treatment Looks Like

Because CRPS is a highly individualized condition, there is currently no single, universally agreed-upon standard protocol for ketamine infusions [12][13]. Treatment plans are tailored to your specific needs.

  • Dosing and Setting: Ketamine for CRPS is administered at a low (sub-anesthetic) dose, meaning it is much lower than the amount used for surgical anesthesia [1]. It can be given in an outpatient clinic over a few hours or, in more severe cases, as a continuous infusion in an inpatient hospital setting over several days or up to two weeks [2][14].
  • Preparation and Logistics: If you are receiving outpatient infusions, you will likely be asked to fast for a few hours beforehand. Because ketamine will leave you drowsy and disconnected, you must have a designated driver to take you home and a caregiver to stay with you for the rest of the day.
  • The Experience: You will be closely monitored by a medical team. During the infusion, patients often describe feeling relaxed, floating, or disconnected from their surroundings. This is a normal effect of the medication. Some research suggests that longer and more frequent infusions might lead to longer-lasting pain relief, but your doctor will balance this against the risk of side effects [15].
  • Additional Psychiatric Benefits: In addition to pain relief, sub-anesthetic ketamine has been noted to produce rapid improvements in anxiety and depression, which frequently accompany severe chronic pain conditions [16][17].
  • Duration of Relief: The pain relief from an infusion or series of infusions is highly variable. For many patients with chronic, refractory CRPS, the analgesic effect is short-term (lasting weeks or sometimes months), meaning that “booster” or maintenance infusions are often required to sustain the benefits over time [18][19].

Safety and Side Effects

When given at sub-anesthetic doses in a controlled medical setting, ketamine has a favorable safety profile [20][21]. However, as with any advanced therapy, there are potential side effects to be aware of:

  • During the Infusion: The most common side effects include dissociation (feeling detached from your body or reality, clinically known as psychotomimetic experiences) and nausea [22][23]. You may also experience fatigue or drowsiness. These effects are closely monitored and are generally transient, fading quickly once the infusion is stopped or the dose is adjusted [5][4]. Your care team will often administer co-medications—such as anti-nausea drugs or mild sedatives for anxiety—directly into your IV to prevent or manage these immediate side effects.
  • Long-Term Considerations: The medical community is cautious about the long-term, frequent, or very high-dose use of ketamine. High cumulative doses have been linked to more severe risks, including cognitive impairment, potential neurotoxicity, and gallbladder issues (such as swelling or altered bile flow) [24][25]. Because of these risks, your care team will aim to find the lowest effective dose and carefully space out your treatments.

While large clinical trials are still needed to establish the perfect standardized treatment regimen [26][27], many patients with refractory (treatment-resistant) CRPS have found significant relief through properly managed IV ketamine therapy [28][29].

Common questions in this guide

How does ketamine work to stop CRPS pain?
Ketamine acts as an NMDA receptor antagonist to block pain signals. This interrupts central sensitization, essentially turning down the volume of your nervous system and giving it a chance to reset.
What does a ketamine infusion for CRPS feel like?
During the infusion, it is common to feel relaxed, floating, or disconnected from your surroundings, which is known as dissociation. You will also feel drowsy, so a designated driver is required to take you home.
How long does pain relief from ketamine last?
The duration of pain relief varies by patient, but it is typically short-term, lasting weeks or sometimes months. Many patients require maintenance or booster infusions to sustain the benefits.
Who should avoid ketamine infusions?
Ketamine is generally unsafe for individuals with uncontrolled high blood pressure, severe cardiovascular disease, or a history of severe psychiatric conditions like schizophrenia or psychosis.
What are the side effects of IV ketamine therapy?
Immediate side effects often include a feeling of detachment, nausea, and drowsiness, which fade quickly after the infusion. Long-term use of high doses carries risks like cognitive impairment and gallbladder issues.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific ketamine protocol (dose, duration, and frequency) do you recommend for my CRPS, and why?
  2. 2.What co-medications do you include in the IV to help manage side effects like nausea or anxiety during the infusion?
  3. 3.How do you measure whether the treatment is working, and what constitutes a 'successful' outcome for me?
  4. 4.If I get relief, how long does it typically last for your CRPS patients, and how do we handle maintenance or 'booster' infusions?
  5. 5.Am I a safe candidate for this treatment based on my cardiovascular health and psychiatric history?
  6. 6.Is this treatment covered by my insurance, or what out-of-pocket costs should I expect to navigate?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Related questions

Are Opioids Effective for CRPS Nerve Pain?Can CRPS Go Into Full Remission? Prognosis ExplainedDoes Complex Regional Pain Syndrome (CRPS) Spread?Can Vitamin C Prevent CRPS After Surgery or Fracture?How Does Mirror Therapy Work for CRPS?How Does Weather and Temperature Affect CRPS Pain?Is CRPS Type 2 More Severe Than Type 1? | Inciteful MedExercising with CRPS: Should You Push Through Pain?How to Tell if a CRPS Sympathetic Nerve Block WorkedWhat Causes CRPS After a Fracture or Surgery?What Conditions Are Commonly Mistaken for CRPS?SCS vs DRG Stimulation for CRPS: What's the Difference?Why Are Bisphosphonates Used for CRPS?Why Does a CRPS Limb Turn Cold?

References

References (29)
  1. 1

    Use of Ketamine Infusions for Treatment of Complex Regional Pain Syndrome: A Systematic Review.

    Chitneni A, Patil A, Dalal S, et al.

    Cureus 2021; (13(10)):e18910 doi:10.7759/cureus.18910.

    PMID: 34820225
  2. 2

    Subanesthetic ketamine infusions for the treatment of children and adolescents with chronic pain: a longitudinal study.

    Sheehy KA, Muller EA, Lippold C, et al.

    BMC pediatrics 2015; (15()):198 doi:10.1186/s12887-015-0515-4.

    PMID: 26620833
  3. 3

    Modulation of Magnetic Resonance Spectroscopy Levels of Glutamate and GABA by Ketamine in Treatment-Resistant Depression.

    Njau S, Zavaliangos-Petropulu A, Joshi S, et al.

    Journal of neuroscience research 2026; (104(1)):e70102 doi:10.1002/jnr.70102.

    PMID: 41473990
  4. 4

    Ketamine Use for Cancer and Chronic Pain Management.

    Culp C, Kim HK, Abdi S

    Frontiers in pharmacology 2020; (11()):599721 doi:10.3389/fphar.2020.599721.

    PMID: 33708116
  5. 5

    Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children: The PRIME Randomized Clinical Trial.

    Frey TM, Florin TA, Caruso M, et al.

    JAMA pediatrics 2019; (173(2)):140-146 doi:10.1001/jamapediatrics.2018.4582.

    PMID: 30592476
  6. 6

    Pain Science in Practice (Part 4): Central Sensitization I.

    Hoegh M

    The Journal of orthopaedic and sports physical therapy 2023; (53(1)):1-4 doi:10.2519/jospt.2023.11569.

    PMID: 36587264
  7. 7

    Treatment response to low-dose ketamine infusion for treatment-resistant depression: A gene-based genome-wide association study.

    Chen MH, Kao CF, Tsai SJ, et al.

    Genomics 2021; (113(2)):507-514 doi:10.1016/j.ygeno.2020.12.030.

    PMID: 33370585
  8. 8

    Antidepressant Actions of Ketamine: Potential Role of L-Type Calcium Channels.

    Robinson B, Gu Q, Kanungo J

    Chemical research in toxicology 2021; (34(5)):1198-1207 doi:10.1021/acs.chemrestox.0c00411.

    PMID: 33566591
  9. 9

    [Ketamine infusion therapy in treatment-resistant depression].

    Christodoulakis ΤΕ

    Psychiatrike = Psychiatriki 2021; (32(Supplement I)):64-69 doi:10.22365/jpsych.2021.051.

    PMID: 34990381
  10. 10

    Ketamine for Treatment-Resistant Mood Disorders.

    Park LT, Falodun TB, Zarate CA

    Focus (American Psychiatric Publishing) 2019; (17(1)):8-12 doi:10.1176/appi.focus.20180030.

    PMID: 31975953
  11. 11

    Ketamine Therapy in Complex Cases: A Cautionary Tale of Exacerbated Personality Traits and the Crucial Role of Comprehensive Follow-Up and Psychosocial Interventions.

    Ahuja J, Leontieva L

    Case reports in psychiatry 2024; (2024()):2143372 doi:10.1155/2024/2143372.

    PMID: 38939043
  12. 12

    Ketamine for Complex Regional Pain Syndrome: A Narrative Review Highlighting Dosing Practices and Treatment Response.

    Lii TR, Singh V

    Anesthesiology clinics 2023; (41(2)):357-369 doi:10.1016/j.anclin.2023.03.005.

    PMID: 37245947
  13. 13

    Intravenous Ketamine Infusions for Neuropathic Pain Management: A Promising Therapy in Need of Optimization.

    Maher DP, Chen L, Mao J

    Anesthesia and analgesia 2017; (124(2)):661-674 doi:10.1213/ANE.0000000000001787.

    PMID: 28067704
  14. 14

    The effects of a multiday (10-14 days) subanesthetic dose IV ketamine infusion in the treatment of refractory chronic pain.

    Chebini A, Marzoughi S, Randhawa J, et al.

    Pain management 2022; (12(3)):337-346 doi:10.2217/pmt-2021-0064.

    PMID: 34528840
  15. 15

    Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia.

    Pastrak M, Abd-Elsayed A, Ma F, et al.

    Ochsner journal 2021; (21(4)):387-394 doi:10.31486/toj.21.0038.

    PMID: 34984054
  16. 16

    Therapeutic effects of 7- to 14-day subanesthetic ketamine infusions for chronic pain on standardized psychiatric measures.

    Marzoughi S, Ripsman D, Ong M

    Pain management 2023; (13(9)):529-538 doi:10.2217/pmt-2023-0066.

    PMID: 37656045
  17. 17

    IV low dose ketamine infusions for treatment resistant depression: Results from a five-year study at a free public clinic in an academic hospital.

    Gutierrez G, Kang MJY, Vazquez G

    Psychiatry research 2024; (335()):115865 doi:10.1016/j.psychres.2024.115865.

    PMID: 38518518
  18. 18

    Adverse drug effects related to multiday ketamine infusions: multicenter study.

    Mendelson AM, Kohan L, Okai J, et al.

    Regional anesthesia and pain medicine 2020; doi:10.1136/rapm-2019-101173.

    PMID: 32054666
  19. 19

    Results of the Treatment of Chronic, Refractory CRPS with Ketamine Infusions: a Preliminary Report.

    Puchalski P, Zyluk A

    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... 2016; (48(3)):143-7 doi:10.1055/s-0042-108650.

    PMID: 27311072
  20. 20

    Efficacy and Safety of Pharmacological Treatment in Patients with Complex Regional Pain Syndrome: A Systematic Review and Meta-Analysis.

    Zhu H, Wen B, Xu J, et al.

    Pharmaceuticals (Basel, Switzerland) 2024; (17(6)) doi:10.3390/ph17060811.

    PMID: 38931478
  21. 21

    Refractory symptoms in paediatric palliative care: can ketamine help?

    Benini F, Congedi S, Giacomelli L, et al.

    Drugs in context 2021; (10()) doi:10.7573/dic.2021-2-5.

    PMID: 34104198
  22. 22

    Ketamine - An Imperfect Wonder Drug?

    Magruder T, Isenhart M, Striepe MV, et al.

    Biochemical pharmacology 2024; (229()):116516 doi:10.1016/j.bcp.2024.116516.

    PMID: 39218043
  23. 23

    In Search of Solutions for Chronic Pain: A Meta-analysis of Ketamine Infusions.

    Nathan N

    Anesthesia and analgesia 2019; (129(1)):1 doi:10.1213/ANE.0000000000004244.

    PMID: 31206441
  24. 24

    The Effects of Long-Term Ketamine Treatment on Cognitive Function in Complex Regional Pain Syndrome: A Preliminary Study.

    Kim M, Cho S, Lee JH

    Pain medicine (Malden, Mass.) 2016; (17(8)):1447-51 doi:10.1093/pm/pnv112.

    PMID: 26921891
  25. 25

    Recurrent Subanesthetic Ketamine Infusions for Complex Regional Pain Syndrome Leading to Biliary Dilation, Jaundice, and Cholangitis: A Case Report.

    Hewitt NA, Cox P

    A&A practice 2018; (10(7)):168-170 doi:10.1213/XAA.0000000000000650.

    PMID: 29135531
  26. 26

    The Analgesic Efficacy of Therapies Used for Complex Regional Pain Syndrome: A Systematic Review.

    Shekarsarai C, McQuibban NA, Gullick N

    Cureus 2025; (17(9)):e91697 doi:10.7759/cureus.91697.

    PMID: 40917914
  27. 27

    Optimizing the Treatment of CRPS With Ketamine.

    Kirkpatrick AF, Saghafi A, Yang K, et al.

    The Clinical journal of pain 2020; (36(7)):516-523 doi:10.1097/AJP.0000000000000831.

    PMID: 32243301
  28. 28

    The Use of Ketamine for Malignant and Nonmalignant Chronic Pain in Children: A Review of Current Evidence.

    AlGhamdi K, Sadler K

    Journal of pain & palliative care pharmacotherapy 2024; (38(1)):45-55 doi:10.1080/15360288.2023.2284976.

    PMID: 38010998
  29. 29

    Effect of intravenous low-dose S-ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study.

    Mangnus TJP, Dirckx M, Bharwani KD, et al.

    Pain practice : the official journal of World Institute of Pain 2021; (21(8)):890-897 doi:10.1111/papr.13056.

    PMID: 34233070

This page provides information on IV ketamine therapy for CRPS for educational purposes only. Always consult your pain management specialist or physician to determine if this treatment is safe and appropriate for you.

Get notified when new evidence is published on Complex regional pain syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.